Skip to main content
Log in

Kinase activity of mutant LRRK2 mediates neuronal toxicity

  • Brief Communication
  • Published:

From Nature Neuroscience

View current issue Submit your manuscript

Abstract

Mutations in the the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson disease and some cases of sporadic Parkinson disease. Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity. These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Alteration of the key residues of LRRK2 reduces its kinase activity in an autophosphorylation assay.
Figure 2: Alteration of mutant LRRK2 activity reduces its neuronal toxicity.
Figure 3: Binding of GTP to LRRK2 requires the GTPase-like Roc domain and leads to stimulation of LRRK2 kinase activity.

Similar content being viewed by others

References

  1. Paisan-Ruiz, C. et al. Neuron 44, 595–600 (2004).

    Article  CAS  Google Scholar 

  2. Zimprich, A. et al. Neuron 44, 601–607 (2004).

    Article  CAS  Google Scholar 

  3. Di Fonzo, A. et al. Lancet 365, 412–415 (2005).

    Article  CAS  Google Scholar 

  4. Gilks, W.P. et al. Lancet 365, 415–416 (2005).

    CAS  PubMed  Google Scholar 

  5. Morris, H.R. Ann. Med. 37, 86–96 (2005).

    Article  CAS  Google Scholar 

  6. Gasser, T. Curr. Opin. Neurol. 18, 363–369 (2005).

    Article  CAS  Google Scholar 

  7. Farrer, M. et al. Neurology. 65, 738–740 (2005).

    Article  CAS  Google Scholar 

  8. Albrecht, M. Lancet 365, 1230 (2005).

    Article  Google Scholar 

  9. West, A.B. et al. Proc. Natl. Acad. Sci. USA 102, 16842–16847 (2005).

    Article  CAS  Google Scholar 

  10. Gloeckner, C.J. et al. Hum. Mol. Genet. 15, 223–232 (2006).

    Article  CAS  Google Scholar 

  11. Greggio, E. et al. Neurobiol. Dis. 23, 329–341 (2006).

    Article  CAS  Google Scholar 

  12. Smith, W.W. et al. Proc. Natl. Acad. Sci. USA 102, 18676–18681 (2005).

    Article  CAS  Google Scholar 

  13. Bosgraaf, L. & van Haastert, P.J. Biochim. Biophys. Acta 1643, 5–10 (2003).

    Article  CAS  Google Scholar 

  14. Korr, D. et al. Cell. Signal. 18, 910–920 (2006).

    Article  CAS  Google Scholar 

  15. Praefcke, G.J. et al. J. Mol. Biol. 344, 257–269 (2004).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the US National Institutes of Health, the National Institute of Neurological Disorders and Stroke (R21NS055684-01 and NS38377) and the National Parkinson's Disease Foundation.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Wanli W Smith or Christopher A Ross.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, W., Pei, Z., Jiang, H. et al. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9, 1231–1233 (2006). https://doi.org/10.1038/nn1776

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn1776

  • Springer Nature America, Inc.

This article is cited by

Navigation